Intron A
(interferon)Phase 3Small molecule
SanofiInterferon is used to treat certain viral infections like hepatitis C and some cancers by helping the immune system fight disease. It can also be used for multiple sclerosis to reduce the frequency of relapses.[1] Intron A is currently being investigated across 9 indications[3], with its most advanced program in Phase 3.[1]
Intron A is one of 179 small molecule programs targeting Hepatitis B Virus Infection. It is currently in Phase 3.
9
Indications
25
Total Trials
4
Active Trials
178
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
235 competitors in Acute Myeloid Leukemia
#DrugCompanyPhaseTrials
1Novantrone
PfizerPhase 3
Xospata
AstellasPhase 3
Fludara
SanofiPhase 3
Vepesid
AAvyxa
Phase 3
Cerubidine
HHikma Pharmaceuticals LLC
Phase 3
Mylotarg
WWyeth-Lederle Vaccines
Phase 3
Cerubidine
HHikma Pharmaceuticals LLC
Phase 3
Neupogen
EEastern Cooperative Oncology Group
Phase 3
Cellcept
RochePhase 3
Busulfex
Akero TherapeuticsPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Chronic Hepatitis7 trials
Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B
Completed·—··NCT04028856·400 enrolled
An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis C
Unknown status·—··NCT04301882·1,000 enrolled
Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C
Unknown status·—··NCT04071353·1,000 enrolled
Show 4 more trials
Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral Therapy
Unknown status·—··NCT05792878·600 enrolled
A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis
Unknown status·—··NCT04301908·10,000 enrolled
Multiple Sclerosis2 trials
Melanoma1 trial
13 more indications
Lymphoma1 trial
Acute Myeloid Leukemia1 trial
Immunotherapy1 trial
Monotherapy1 trial
Chronic HBV Infection1 trial
Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned Intervention
Unknown status·—··NCT04030039·420 enrolled
Chronic Lymphocytic Leukemia1 trial
Interstitial Cystitis1 trial
Zollinger-Ellison Syndrome1 trial
Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
Completed·NNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·Phase 2·NCT00001228·50 enrolled
Metastatic Melanoma1 trial
Acute Lymphoblastic Leukemia1 trial
HBV Infection1 trial
Antiviral Therapy in Infants With HBV Infection
Not yet recruiting·—·Phase 4·NCT06503796·60 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for interferon. EMBL-EBI & Wellcome Sanger Institute.
- [4]